World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Andrew D. Lipman net worth and biography

Andrew Lipman Biography and Net Worth

Director of Nu Skin Enterprises

Andrew D. Lipman has served as a director of Nu Skin since May 1999. He is a partner and head of the Telecommunications, Media and Technology Group at Morgan, Lewis & Bockius LLP, an international law firm that he joined in 2014. He previously held similar positions with Bingham McCutchen LLP from 2006 to 2014 and Swidler Berlin, LLP from 1988 to 2006.

From 1987 to 1997, Lipman also served as senior vice president for legal and regulatory affairs for MFS Communications, Co., a competitive telecommunications provider. He also served as a member of the boards of directors of Sutron Corporation, a provider of hydrological and meteorological monitoring products, and The Management Network Group, Inc., a telecommunications-related consulting firm. He received a bachelor's degree from the University of Rochester and a Juris Doctorate degree from Stanford University.

What is Andrew D. Lipman's net worth?: The estimated net worth of Andrew D. Lipman is at least $337,317.75 as of March 25th, 2024. Mr. Lipman owns 27,225 shares of Nu Skin Enterprises stock worth more than $337,318 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Lipman may own. Learn More about Andrew D. Lipman's net worth.
How do I contact Andrew D. Lipman?: The corporate mailing address for Mr. Lipman and other Nu Skin Enterprises executives is 75 WEST CENTER ST, PROVO UT, 84601. Nu Skin Enterprises can also be reached via phone at (801) 345-1000 and via email at [email protected]. Learn More on Andrew D. Lipman's contact information.
Has Andrew D. Lipman been buying or selling shares of Nu Skin Enterprises?: Andrew D. Lipman has not been actively trading shares of Nu Skin Enterprises during the last ninety days. Most recently, Andrew D. Lipman sold 2,000 shares of the business's stock in a transaction on Monday, March 25th. The shares were sold at an average price of $12.32, for a transaction totalling $24,640.00. Following the completion of the sale, the director now directly owns 27,225 shares of the company's stock, valued at $335,412. Learn More on Andrew D. Lipman's trading history.
Who are Nu Skin Enterprises' active insiders?: Nu Skin Enterprises' insider roster includes Jeffrey Bettinger (SVP), Joseph Chang (EVP), D. Dorny (General Counsel), Andrew Lipman (Director), and Ritch Wood (CEO). Learn More on Nu Skin Enterprises' active insiders.
Are insiders buying or selling shares of Nu Skin Enterprises?: During the last twelve months, insiders at the sold shares 16 times. They sold a total of 47,995 shares worth more than $1,062,521.81. The most recent insider tranaction occured on March, 25th when Director Andrew D Lipman sold 2,000 shares worth more than $24,640.00. Insiders at Nu Skin Enterprises own 1.7% of the company. Learn More about insider trades at Nu Skin Enterprises.
Information on this page was last updated on 3/25/2024.

Andrew D. Lipman Insider Trading History at Nu Skin Enterprises

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/25/2024	Sell	2,000	$12.32	$24,640.00	27,225
2/26/2024	Sell	2,000	$12.46	$24,920.00	29,225
1/25/2024	Sell	2,000	$18.55	$37,100.00	31,225
12/26/2023	Sell	2,000	$19.39	$38,780.00	33,225
11/27/2023	Sell	2,000	$17.11	$34,220.00	35,225
11/3/2023	Sell	15,400	$17.68	$272,272.00	37,225
10/25/2023	Sell	2,000	$19.23	$38,460.00	52,625
9/25/2023	Sell	2,000	$23.02	$46,040.00	54,625
8/25/2023	Sell	2,000	$23.33	$46,660.00	56,625
7/25/2023	Sell	2,000	$28.99	$57,980.00	58,625
6/26/2023	Sell	2,000	$32.12	$64,240.00	60,625
5/25/2023	Sell	2,000	$34.28	$68,560.00	58,393
4/25/2023	Sell	2,000	$40.75	$81,500.00	60,393
3/27/2023	Sell	2,000	$39.29	$78,580.00	62,393
1/23/2023	Sell	1,000	$42.27	$42,270.00	65,393
12/22/2022	Sell	1,000	$40.75	$40,750.00	66,393
11/22/2022	Sell	1,000	$38.16	$38,160.00	67,393
10/21/2022	Sell	1,000	$35.92	$35,920.00	68,393
9/22/2022	Sell	1,000	$36.67	$36,670.00	69,393
8/22/2022	Sell	1,000	$45.01	$45,010.00	70,393
7/22/2022	Sell	1,000	$43.00	$43,000.00	71,393
6/22/2022	Sell	1,000	$44.06	$44,060.00	72,393
5/23/2022	Sell	1,000	$44.95	$44,950.00	70,214
4/22/2022	Sell	1,000	$47.72	$47,720.00	71,214
3/22/2022	Sell	1,000	$47.40	$47,400.00
2/22/2022	Sell	1,000	$53.27	$53,270.00
1/24/2022	Sell	1,000	$50.50	$50,500.00
9/22/2016	Sell	30,000	$64.13	$1,923,900.00	36,090

Andrew D. Lipman Buying and Selling Activity at Nu Skin Enterprises

Nu Skin Enterprises Company Overview

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Today's Range

Now: $12.24

$12.10

$12.44

50 Day Range

MA: $12.80

$12.01

$13.83

2 Week Range

Now: $12.24

$11.84

$40.68

Volume

467,771 shs

Average Volume

753,500 shs

Market Capitalization

$604.90 million

P/E Ratio

68.00

Dividend Yield

1.88%

Beta

1.11

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Click here to find out what to do.